Published in J Clin Oncol on April 01, 2005
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol (2008) 4.69
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol (2010) 2.83
Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol (2009) 1.94
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol (2009) 1.79
Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med (2012) 1.61
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma. Cancer (2015) 1.43
Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol (2008) 1.42
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog (2010) 1.40
Merkel cell carcinoma. World J Surg Oncol (2006) 1.33
Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol (2009) 1.28
Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol (2007) 1.27
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer (2009) 1.26
Drug-conjugated antibodies for the treatment of cancer. Br J Clin Pharmacol (2013) 1.18
Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol (2011) 1.16
Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol (2011) 1.14
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol (2013) 1.03
Neuroendocrine (Merkel cell) carcinoma of the retroperitoneum with no identifiable primary site. World J Surg Oncol (2007) 0.98
Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol (2012) 0.97
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331). Am J Clin Oncol (2010) 0.96
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. J Virol Methods (2012) 0.96
An update on nonmelanoma skin cancer. J Clin Aesthet Dermatol (2011) 0.95
Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine (2011) 0.95
Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol (2014) 0.94
Merkel cell carcinoma: the past, the present, and the future. J Skin Cancer (2013) 0.92
Thoracic spinal metastasis of merkel cell carcinoma in an immunocompromised patient: case report. Evid Based Spine Care J (2013) 0.91
The role of the immune response in merkel cell carcinoma. Cancers (Basel) (2013) 0.91
G3139 (Genasense) in patients with advanced merkel cell carcinoma. Am J Clin Oncol (2009) 0.90
Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: case report and literature review. World J Surg Oncol (2005) 0.90
Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany. MAbs (2012) 0.90
A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg (2013) 0.89
A review of the epidemiology and treatment of Merkel cell carcinoma. Clinics (Sao Paulo) (2011) 0.89
Molecular imaging of neuroendocrine tumors. Semin Oncol (2010) 0.89
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer (2013) 0.86
Therapeutic options for treatment of Merkel cell carcinoma. Eur Arch Otorhinolaryngol (2010) 0.85
Sentinel lymph node biopsy in nonmelanoma skin cancer patients. J Skin Cancer (2013) 0.84
Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status. Hum Pathol (2010) 0.84
The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature. Front Oncol (2013) 0.84
Merkel cell carcinoma dependence on bcl-2 family members for survival. J Invest Dermatol (2014) 0.84
Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor. PLoS One (2013) 0.83
Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer (2013) 0.83
Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. J Clin Oncol (2005) 0.83
Merkel cell carcinoma: a retrospective study on 48 cases and review of literature. J Oncol (2012) 0.83
Merkel cell carcinoma. Am J Clin Oncol (2013) 0.83
Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases. Int J Clin Oncol (2014) 0.83
Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw (2014) 0.82
A comparison of merkel cell carcinoma and melanoma: results from the california cancer registry. Clin Med Oncol (2008) 0.82
Merkel cell carcinoma with lymph node metastasis in the absence of a primary site: Case report and literature review. Oncol Lett (2012) 0.82
Ileocaecal recurrence of Merkel cell carcinoma of the skin: a case report. J Med Case Rep (2010) 0.81
Merkel cell carcinoma metastatic to the small bowel mesentery. Rare Tumors (2011) 0.80
Merkel cell carcinoma of the eyelid and periocular region. Cancers (Basel) (2014) 0.80
Molecular imaging and therapy of merkel cell carcinoma. Cancers (Basel) (2014) 0.80
Gastric metastasis of Merkel cell carcinoma, a rare cause of gastrointestinal bleeding: case report and review of the literature. J Gastrointest Oncol (2014) 0.80
Merkel cell carcinoma of skin-current controversies and recommendations. Rare Tumors (2011) 0.80
The clinical profile of Merkel cell carcinoma in mainland China. Int J Dermatol (2012) 0.80
[Merkel cell carcinoma]. Pathologe (2014) 0.80
Inflammatory cell distribution in primary merkel cell carcinoma. Cancers (Basel) (2014) 0.80
Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma. Cancer Med (2016) 0.80
An unusual case of Merkel cell carcinoma. J Cancer Res Clin Oncol (2007) 0.79
Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options. Onco Targets Ther (2015) 0.79
A review of radiotherapy for merkel cell carcinoma of the head and neck. J Skin Cancer (2012) 0.79
Design of potential siRNA molecules for T antigen gene silencing of Merkel Cell Polyomavirus. Bioinformation (2012) 0.79
The role of free tissue transfer in merkel cell carcinoma of the head and neck. J Skin Cancer (2012) 0.79
Secondary merkel cell carcinoma manifested in the parotid. Case Rep Dermatol Med (2013) 0.78
Role of sentinel lymph node biopsy in the management of merkel cell carcinoma. J Skin Cancer (2012) 0.78
Merkel cell carcinoma of the upper extremity: case report and an update. World J Surg Oncol (2008) 0.78
Cerebral metastases from Merkel cell carcinoma: long-term survival. J Surg Case Rep (2016) 0.77
Merkel cell tumor of the skin treated with localized radiotherapy: are widely negative margins required? Rare Tumors (2011) 0.77
Merkel cell carcinoma of left groin: a case report and literature review. Case Rep Oncol Med (2013) 0.77
Clinical emergence of neurometastatic merkel cell carcinoma: a surgical case series and literature review. J Neurooncol (2010) 0.77
Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma. Radiat Oncol (2012) 0.77
Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma. Virchows Arch (2009) 0.77
Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review. Clin Ophthalmol (2011) 0.76
Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. Cancer J (2013) 0.76
Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol (2014) 0.76
Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival. Cancer Immunol Res (2017) 0.76
A unique case of merkel cell carcinoma and chronic lymphocytic leukaemia presenting in a single cutaneous lesion (collision tumour). BMJ Case Rep (2009) 0.76
Primary neuroendocrine carcinoma of ocular adnexa. Case Rep Ophthalmol Med (2013) 0.75
Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management. Cancer Imaging (2013) 0.75
Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies. Cancers (Basel) (2014) 0.75
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients. Mod Pathol (2015) 0.75
Radiation therapy in the management of Merkel cell carcinoma: current perspectives. Expert Rev Dermatol (2011) 0.75
A case of long-term survival following hepatectomy for liver metastasis of Merkel cell carcinoma. Surg Case Rep (2015) 0.75
Radiotherapy for metastatic merkel cell carcinoma: a review of the literature. J Skin Cancer (2012) 0.75
Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma. Intern Med (2017) 0.75
Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience. PLoS One (2015) 0.75
Merkel Cell Carcinoma of the Hand: A Case Report and Review of the Literature. Hand (N Y) (2016) 0.75
Merkel cell carcinoma of unknown primary with lymph node and mesenteric metastasis involving the pancreas and duodenum. J Gastrointest Oncol (2016) 0.75
Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma. Am J Dermatopathol (2014) 0.75
Merkel cell carcinoma of the cheek: diagnosis in an elderly woman. Ulster Med J (2007) 0.75
Merkel Cell Spinal Metastasis: Management in the Setting of a Poor Prognosis. Global Spine J (2015) 0.75
Giant Merkel cell carcinoma of the eyelid: a case report and review of the literature. World J Surg Oncol (2011) 0.75
Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. J Clin Oncol (2005) 0.75
Primary retroperitoneal Merkel cell carcinoma: Case report and literature review. Int J Surg Case Rep (2015) 0.75
Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence? Int Ophthalmol Clin (2015) 0.75
Multiple Primary Merkel Cell Carcinomas Presenting as Pruritic, Painful Lower Leg Tumors. Case Rep Dermatol (2015) 0.75
Merkel cell carcinoma in organ transplant recipients: Case reports and review of the literature. JAAD Case Rep (2015) 0.75
A case series and literature review of Merkel cell carcinoma metastasizing to pancreas. Dig Dis Sci (2015) 0.75
An elderly man with a solitary liver lesion. Cytojournal (2017) 0.75
Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report. BMC Res Notes (2017) 0.75
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma? Onco Targets Ther (2017) 0.75
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (2009) 8.69
Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol (2006) 7.76
Mutations in GNA11 in uveal melanoma. N Engl J Med (2010) 7.52
Clinicopathologic correlates of solitary fibrous tumors. Cancer (2002) 5.96
Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res (2005) 5.44
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg (2003) 4.25
Quality of complication reporting in the surgical literature. Ann Surg (2002) 4.21
Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol (2005) 3.99
Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol (2002) 3.96
Pasireotide for postoperative pancreatic fistula. N Engl J Med (2014) 3.84
Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst (2003) 3.65
Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol (2002) 3.60
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol (2003) 3.56
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2006) 3.34
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg (2006) 3.23
Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer (2008) 3.10
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99
Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. J Am Coll Surg (2010) 2.98
Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg (2004) 2.86
A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J (2005) 2.71
Clinicopathological features of and risk factors for multiple primary melanomas. JAMA (2005) 2.62
Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res (2003) 2.62
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg (2004) 2.62
Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg (2003) 2.54
Adult spermatic cord sarcomas: management and results. Ann Surg Oncol (2003) 2.52
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell (2012) 2.50
Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg (2002) 2.47
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res (2002) 2.41
Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol (2002) 2.39
Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg (2005) 2.38
Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg (2007) 2.37
The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery (2002) 2.32
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res (2003) 2.32
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience. J Urol (2006) 2.30
Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg (2013) 2.29
The value of splenic preservation with distal pancreatectomy. Arch Surg (2002) 2.27
American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. Ann Surg (2005) 2.25
Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg (2012) 2.23
Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg (2007) 2.22
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19
An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin (2004) 2.18
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol (2003) 2.18
Results after pancreatic resection for metastatic lesions. Ann Surg Oncol (2002) 2.15
Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol (2005) 2.12
Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg (2007) 2.12
Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol (2009) 2.10
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst (2005) 2.10
Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol (2004) 2.09
Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08
Primary mucosal malignant melanoma of the head and neck. Head Neck (2002) 2.07
Conventional hemangiopericytoma: modern analysis of outcome. Cancer (2002) 2.04
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg (2010) 1.98
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol (2008) 1.97
The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg (2004) 1.97
Metastasis to the adrenal gland: the emerging role of laparoscopic surgery. Ann Surg Oncol (2003) 1.97
Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol (2003) 1.94
Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol (2003) 1.92
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol (2002) 1.89
Primary vaginal melanoma: a critical analysis of therapy. Ann Surg Oncol (2004) 1.87
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87
Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg (2007) 1.86
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol (2010) 1.85
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Ann Surg Oncol (2007) 1.84
A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol (2005) 1.83
Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol (2009) 1.82
Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol (2004) 1.82
Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer (2002) 1.82
Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res (2003) 1.81
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res (2006) 1.80
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol (2006) 1.80
Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol (2004) 1.80
Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg (2004) 1.80
Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst (2008) 1.78
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol (2005) 1.76
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev (2007) 1.76
Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg (2007) 1.75